Ligand validation:9FDV

MPO: 3[N-MORPHOLINO]PROPANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9FDV_MPO_D_504	25%	44%	0.231	0.865	0.54	1.58	-	4	1	0	100%	1
6HLJ_MPO_D_504	72%	57%	0.114	0.938	1.32	0.36	1	-	0	0	100%	1
6HLM_MPO_B_505	64%	37%	0.131	0.928	1.86	0.63	1	-	0	0	100%	0.7
9FE7_MPO_B_504	57%	66%	0.154	0.928	0.69	0.61	1	-	0	0	100%	1
9FIF_MPO_D_503	39%	55%	0.195	0.902	0.62	1.11	1	1	0	0	100%	0.8615
9FE8_MPO_D_503	36%	61%	0.227	0.921	0.73	0.76	1	-	0	0	100%	1
4MZC_MPO_A_201	100%	63%	0.031	0.998	0.43	0.98	-	1	0	0	100%	1
1KJQ_MPO_A_397	100%	25%	0.042	0.99	1.69	1.37	2	2	0	0	100%	1
1KJ9_MPO_A_400	100%	18%	0.046	0.988	2.1	1.42	2	3	0	0	100%	1
1KJI_MPO_A_398	99%	16%	0.052	0.989	1.99	1.7	2	3	0	0	100%	1
4LRQ_MPO_B_201	99%	9%	0.061	0.99	2.22	2.32	2	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.